Monopar Therapeutics Inc.

MNPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$95.72

-$0.75 (-0.78%)

At close: Sep 21, 2026, 4:00 PM ET

$97.94

+$2.22 (+2.32%)

Pre-market: Sep 22, 2026, 8:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-22.12M	-18.71M	-16.7M	-21.62M	-19.11M	-17.66M	-16.16M	-7M	-7.49M	-8.03M	-8.83M	-9.83M	-10.17M	-10.6M	-10.54M	-10.31M	-10.36M	-9.69M	-9.13M	-8.71M	-7.9M	-7.27M
Interest Income	4.24M	3.72M	2.99M	2.18M	1.63M	918.7K	404.02K	353.06K	365.97K	420.72K	429.04K	343.63K	239.06K	111.26K	21.24K	9.1K	1.98K	13.79K	24.02K	33.4K	41.37K	47.46K
Pretax Income	-17.84M	-14.98M	-13.72M	-19.44M	-17.31M	-16.57M	-15.59M	-6.47M	-7.12M	-7.61M	-8.4M	-9.48M	-9.93M	-10.49M	-10.52M	-10.3M	-10.36M	-9.68M	-9.1M	-8.55M	-7.73M	-7.1M
Net Income	-17.84M	-14.98M	-13.72M	-19.44M	-17.31M	-16.57M	-15.59M	-6.47M	-7.12M	-7.61M	-8.4M	-9.48M	-9.93M	-10.49M	-10.52M	-10.3M	-10.36M	-9.68M	-9.1M	-8.55M	-7.73M	-7.1M
Selling & General & Admin	1.74B	1.74B	6.8M	5.74M	4.82M	3.98M	3.16M	2.88M	3.04M	3.12M	3.23M	3.16M	3.09M	3.04M	2.95M	2.84M	2.79M	2.73M	2.63M	2.56M	2.32M	2.34M
Research & Development	14.78M	11.75M	9.9M	15.89M	14.28M	13.68M	13.01M	4.12M	4.45M	4.91M	5.6M	6.67M	7.08M	7.57M	7.59M	7.47M	7.57M	6.96M	6.49M	6.14M	5.57M	4.93M
Other Expenses	-1.74B	-1.74B	-1	-1	n/a	n/a	n/a	0	0	0	0	0	0	0	0	0	0	0	0	0	n/a	n/a
Operating Expenses	22.12M	18.71M	16.7M	21.62M	19.11M	17.66M	16.16M	7M	7.49M	8.03M	8.83M	9.83M	10.17M	10.6M	10.54M	10.31M	10.36M	9.69M	9.13M	8.71M	7.9M	7.27M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-41.5K	-28.03K	-28.03K	-28.03K	13.47K	n/a	n/a
Cost & Expenses	22.12M	18.71M	16.7M	21.62M	19.11M	17.66M	16.16M	7M	7.49M	8.03M	8.83M	9.83M	10.17M	10.6M	10.54M	10.31M	10.36M	9.69M	9.13M	8.71M	7.9M	7.27M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	8.54M	8.54M	6.69M	7.12M	7M	6.91M	11.44M	11.44M	11.44M	15.98M	14.9M	14.12M	13.42M	13.11M	12.95M	12.76M	12.63M	12.6M	12.58M	12.58M	12.57M	12.14M
Shares Outstanding (Diluted)	8.54M	8.54M	6.69M	7.12M	7M	6.99M	11.48M	11.48M	11.48M	15.98M	14.9M	14.12M	13.42M	13.11M	12.95M	12.76M	12.63M	12.6M	12.58M	12.58M	12.57M	12.14M
EPS (Basic)	-2.34	-2.07	-1.99	-2.16	-1.79	-1.59	-1.31	-0.48	-0.51	-0.52	-0.61	-0.71	-0.76	-0.82	-0.82	-0.81	-0.82	-0.77	-0.74	-0.72	-0.67	-0.64
EPS (Diluted)	-2.34	-2.07	-1.99	-2.16	-1.79	-1.59	-1.31	-0.48	-0.51	-0.52	-0.61	-0.71	-0.76	-0.82	-0.82	-0.81	-0.82	-0.77	-0.74	-0.72	-0.67	-0.64
EBITDA	-18.5M	-15.64M	-14.37M	-20.1M	-17.31M	-16.57M	-15.59M	-4.56M	-5.21M	-5.7M	-6.49M	-6.58M	-7.02M	-7.58M	-7.61M	-7.62M	-5.22M	-4.54M	-3.97M	-3.97M	-5.62M	-5.01M
EBIT	-18.5M	-15.64M	-14.37M	-20.1M	-17.31M	-16.57M	-15.59M	-6.47M	-7.12M	-7.61M	-8.4M	-9.48M	-9.93M	-10.49M	-10.52M	-10.3M	-10.36M	-9.68M	-9.11M	-8.69M	-7.88M	-7.27M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.91M	1.91M	1.91M	1.91M	2.91M	2.91M	2.91M	2.91M	2.68M	5.14M	5.14M	5.14M	4.72M	2.26M	2.26M